Skip to main content
. 2012 Jun 24;7:103. doi: 10.1186/1748-717X-7-103

Table 1.

Patient and treatment characteristics with comparison between EFI and TNI and between stages I/II and stage III disease

  All EFI TNI p-value Stage I/II Stage III p-value
# patients
107
 
48
 
59
 
 
86
21
 
Age
 
 
 
 
 
 
<0.001
 
 
 
 
<0.001
 median/range [years]
57
26 - 83
66
37 - 83
51
26 - 74
 
61
27 – 83
51
26 - 68
 
 ≥60 years
48
45%
35
73%
13
22%
 
45
52%
3
14%
 
Sex [male]
59
57%
26
55%
33
56%
NS
49
57%
10
48%
 
Karnofsky Performance status
 
 
 
 
 
 
<0.001
 
 
 
 
NS
median/range
90
50 - 100
90
50 - 100
100
80 - 100
 
90
50 – 100
90
70 – 100
 
B-Symptoms
1
1%
0
0%
1
2%
NS
0
0%
1
5%
NS
LDH
 
 
 
 
 
 
NS
 
 
 
 
0.03
 Elevated
16
15%
9
19%
7
12%
 
8
9%
8
38%
 
 Normal
63
59%
29
60%
34
58%
 
55
64%
8
24%
 
 unknown
28
26%
10
21%
18
30%
 
23
27%
5
38%
 
Ann Arbor stage
 
 
 
 
 
 
0.04
 
 
 
 
 
 I
50
47%
27
56%
23
39.0%
 
 
 
 
 
 
 II
36
34%
18
38%
18
30.5%
 
 
 
 
 
 
 III
21
20%
3
6%
18
30.5%
 
 
 
 
 
 
Bulk ≥7.5 cm
5
5%
2
4%
3
5%
NS
3
3%
2
9%
NS
Radiotherapy dose median/range [Gy] 38 25 - 50 38 27 - 50 37 25 - 46 NS 37 25 - 50 37 29 - 46 NS